The High Throughput Screening Market size in Latin America is anticipated to grow at 8.12% CAGR from 2020 to 2025, and it is estimated that the Latin American market was valued at USD 1.94 billion in 2020 is expected to reach USD 2.87 billion by 2025.
The significant factors which are propelling the growth of Latin America high throughput screening market are advancements of technologies leading to the emergence of innovative technologies and platforms like analytical tools that deal with massive amounts of data. Increasing demand and a growing number in applications of high throughput screening devices in the pharmacy industry, collaborations of research and academic institutions with pharmaceutical industries for developing innovative ways for drug delivery, rise in outsourced drug discovery services, availability of government funding, increase in demand for high throughput screening devices in stem cell research for the assessment of excretion, metabolism, distribution, and absorption characteristics and investigation of functional activity.
Evolution of preclinical drug development and discovery systems, through the adoption of human stem cell-based high throughput screenings and assays are further providing growth scope for the market.
Increasing economies of Latin American countries, rise in the number of patients, and the elderly population is the factors that are likely to create more opportunities and contribute to the development and growth of the High throughput screening market in Latin America during the estimated forecast period.
Regulatory bodies, maintenance costs, and limited investments in research due to the lack of advanced technologies are major restraints to the high Latin America throughput screening market.
This research report has been segmented and sub-segmented into the following categories:
By End User:
Regionally, Latin America is projected to witness lucrative growth in the coming years. It can be attributed to the growing R&D spending, the rising trend of outsourcing drug discovery services, growing public-private partnerships, and increasing government funding.
Brazil is leading the Latin American market with the largest share due to the increasing number of patients, rising geriatric population, which creates more chances and presents to the development and growth of Latin America's market during the assessment period.
Mexico is the next leading country followed by Brazil to have the highest share as a result of technological advancements, funds, and investments towards the research and development activities and broad utilization of high throughput screening technology for pharmaceutical and biotechnology companies in the drug discovery process is projected to accelerate the market growth throughout the esteemed period.
Prominent companies leading in the Latin America High Throughput Screening Market profiled in the report are Agilent Technologies Inc., Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Tecan Group Ltd., Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam S.p.A., and Aurora Biomed.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Consumables and Reagents
5.1.4 Software and Services
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2.2 Cell-based Assays
22.214.171.124 2D Cell Culture
126.96.36.199 3D Cell Culture
188.8.131.52.1 Scaffold-Based Technology
184.108.40.206.1.2 Inert Matrix/Solid Scaffolds
220.127.116.11.2 Scaffold-Free Technology
18.104.22.168.2.2 Hanging-Drop Plates
22.214.171.124.2.3 Ultra-Low Binding Plates
126.96.36.199.2.4 Other Scaffold-Free Technologies
188.8.131.52 Perfusion Cell Culture
5.2.4 Ultra-High-Throughput Screening
5.2.5 Label-Free Technology
5.2.7 Y-o-Y Growth Analysis, By Technology
5.2.8 Market Attractiveness Analysis, By Technology
5.2.9 Market Share Analysis, By Technology
5.3.2 Target Identification
5.3.3 Primary Screening
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
5.4 End User
5.4.2 Pharmaceutical And Biotechnology Companies
5.4.3 Academic And Government Research Institutes
5.4.4 Contract Research Organizations
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By Technology
22.214.171.124 By Application
126.96.36.199 By End User
6.1.4 Market Attractiveness Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Technology
18.104.22.168 By Application
22.214.171.124 By End User
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Technology
220.127.116.11 By Application
18.104.22.168 By End User
6.4 Rest of Latin America
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Agilent Technologies Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Danaher Corporation
8.3 Thermo Fisher Scientific Inc.
8.4 PerkinElmer Inc.
8.5 Tecan Group Ltd.
8.7 Bio-Rad laboratories
8.8 Hamilton Company
8.9 Axxam S.p.A.
8.10 Aurora Biomed.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures